Founded in 2001, Mycenax Biotech Inc. provides contract development and manufacturing services for biologic drugs, supporting customers from preclinical development and clinical trial material production to commercial-scale manufacturing. With PIC/S GMP-compliant facilities and an experienced R&D team, the company focuses on biologics process development, upstream and downstream processing, analytical methods, formulation development, and fill-finish services. Mycenax continues to expand its advanced biologics platforms, including bispecific and multispecific antibodies, antibody-drug conjugates, nucleic acid therapeutics, and cell therapy-related products, helping global customers accelerate biologics development, technology transfer, and manufacturing.

Login/Register
Supplier Login

















